Women's Health

Black women undergoing treatment for gynecologic cancer reported significantly higher levels of race-associated stress compared with white women, according to study results.

Trastuzumab deruxtecan reduced risk for disease progression or death compared with trastuzumab emtansine among patients with HER2-positive metastatic breast cancer previously treated with trastuzumab and a taxane.

Women diagnosed with breast or gynecologic cancers underutilized both assisted reproductive technology and fertility-sparing oncology care, according to study results.

Folate receptor alpha expression predicted benefit from mirvetuximab soravtansine in platinum-resistant high-grade serous epithelial ovarian, primary peritoneal or fallopian tube cancers, according to a results of the phase 3 SORAYA study.

A trained artificial intelligence model predicted treatment outcomes before surgery of women with high-grade serous ovarian cancer, according to study results.

Women appear to have a higher risk for developing age-related macular degeneration, but the reason for this remains unclear, according to Rishi P. Singh, MD.

Endometriosis is a painful condition estimated to affect 2% to 10% of women in the United States between 25 and 40 years of age, and 10% of reproductive-aged women globally.

Women with preeclampsia reported that they were inadequately educated on the symptoms and long-term risks associated with the condition and said their clinicians largely did not address its mental health impacts.

About one-third of women with commercial insurance underwent genetic testing for ovarian cancer between 2008 and 2018 despite unequivocal recommendations for universal testing, according to research in JAMA Network Open.

Premenopausal women with long or irregular menstrual cycles have a higher risk for prevalent and incident nonalcoholic fatty liver disease compared with women with normal cycles, according to study findings.